Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Shares Issued (2020 - 2025)

Bolt Biotherapeutics' Shares Issued history spans 5 years, with the latest figure at $29000.0 for Q4 2024.

  • For Q4 2024, Shares Issued fell 72.64% year-over-year to $29000.0; the TTM value through Sep 2025 reached $135000.0, down 46.0%, while the annual FY2024 figure was $108000.0, 57.31% down from the prior year.
  • Shares Issued for Q4 2024 was $29000.0 at Bolt Biotherapeutics, down from $106000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $243.6 million in Q4 2021 and bottomed at $5000.0 in Q2 2020.
  • The 5-year median for Shares Issued is $129000.0 (2021), against an average of $18.9 million.
  • The largest annual shift saw Shares Issued skyrocketed 312155.13% in 2021 before it plummeted 99.94% in 2022.
  • A 5-year view of Shares Issued shows it stood at $78000.0 in 2020, then surged by 312155.13% to $243.6 million in 2021, then tumbled by 99.94% to $144000.0 in 2022, then dropped by 26.39% to $106000.0 in 2023, then crashed by 72.64% to $29000.0 in 2024.
  • Per Business Quant, the three most recent readings for BOLT's Shares Issued are $29000.0 (Q4 2024), $106000.0 (Q4 2023), and $144000.0 (Q4 2022).